官方服务：
资源简介：
Variables influencing BChE inhibition.
应用场景：
创建时间：
2018-05-03
相关数据集
Modulation of immune system mediated by ibrutinib in chronic lymphocytic leukemia
Our project is based on the hypothesis that ibrutinib could interfere with chronic lymphocytic leukemia (CLL) microenvironment, modulating the immune response. The aim of the project is to understand
NIAID Data Ecosystem50
Crystal Structure of KPT-330 bound to CRM1 (537-DLTVK-541 to GLCEQ)
Crystal Structure of KPT-330 bound to CRM1 (537-DLTVK-541 to GLCEQ) Descriptor: Exportin-1, GLYCEROL, GTP-binding nuclear protein Ran, ... Authors: Baumhardt, J.M, Chook, Y.M. Deposit date: 2020-12-21
Protein Data Bank Japan2023-10-18 更新20
Crystal structure of covalently modified macrophage inhibitory factor
Crystal structure of covalently modified macrophage inhibitory factor Descriptor: Macrophage migration inhibitory factor Authors: Golubkov, P.A, Hackert, M.L. Deposit date: 2006-03-16 Release date: 20
Protein Data Bank Japan2023-08-30 更新20
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway. Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway
Targeted therapy for patients with EGFR mutations by tyrosine kinase inhibitors (TKIs) has provided a significant benefit to patients. However, gradually developed resistance to the therapy becomes a
NIAID Data Ecosystem30
Genes regulated by JAK1/2 inhibitor ruxolitinib and myxoid liposarcoma-specific fusion onccogene FUS-DDIT3 in HT1080 cells.. Genes regulated by JAK1/2 inhibitor ruxolitinib and myxoid liposarcoma-specific fusion onccogene FUS-DDIT3 in HT1080 cells.
Sarcomas and leukemias that are characterized by FET (FUS, EWSR1, TAF15) fusion oncogenes consist of more than 20 entities. Myxoid liposarcoma, one of the most common FET sarcoma types, is defined by
NIAID Data Ecosystem20
